DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomas-Reference-Cited by-同舟云学术

DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomas

Published:2018-09-25 Issue:2 Volume:21 Page:214-221
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Korshunov Andrey¹²³,Sahm Felix¹²³,Zheludkova Olga⁴,Golanov Andrey⁵,Stichel Damian¹²,Schrimpf Daniel¹²,Ryzhova Marina⁶,Potapov Alexander⁵,Habel Antje¹²,Meyer Jochen¹²,Lichter Peter³⁷,Jones David T W³⁸,von Deimling Andreas¹²³,Pfister Stefan M³⁸⁹,Kool Marcel³⁸

Affiliation:

1. Clinical Cooperation Unit Neuropathology (G380), German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany

2. Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany

3. Hopp Children’s Cancer Center at the National Center for Tumor Diseases Heidelberg, Heidelberg, Germany

4. Department of Neuro-Oncology, Russian Scientific Center of Radiology, Moscow, Russia

5. Department of Neuroradiology, NN Burdenko Neurosurgical Institute, Moscow, Russia

6. Department of Neuropathology, NN Burdenko Neurosurgical Institute, Moscow, Russia

7. Division of Molecular Genetics (B060), German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany

8. Division of Pediatric Neurooncology (B062), German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany

9. Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany

Funder

Helmholtz Association Research

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/21/2/214/27779013/noy155.pdf

Reference29 articles.

1. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas;Kool;Acta Neuropathol,2012

2. The whole-genome landscape of medulloblastoma subtypes;Northcott;Nature,2017

3. Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort;Pietsch;Acta Neuropathol,2014

4. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus;Ramaswamy;Acta Neuropathol,2016

5. Molecular subgroups of medulloblastoma: the current consensus;Taylor;Acta Neuropathol,2012

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of neurosurgical advances and nuances in medulloblastoma therapy;Child's Nervous System;2023-12-19

2. Medulloblastoma targeted therapy: From signaling pathways heterogeneity and current treatment dilemma to the recent advances in development of therapeutic strategies;Pharmacology & Therapeutics;2023-10

3. MBMethPred: a computational framework for the accurate classification of childhood medulloblastoma subgroups using data integration and AI-based approaches;Frontiers in Genetics;2023-09-07

4. High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population;Frontiers in Oncology;2023-09-04

5. Disease Diagnosis Based on Nucleic Acid Modifications;ACS Chemical Biology;2023-08-01